ARTICLE | Company News
ImmunoCellular, California Institute for Regenerative Medicine cancer news
October 5, 2015 7:00 AM UTC
CIRM awarded ImmunoCellular a $19.9 million grant to fund a Phase III trial of the company’s ICT-107 to treat newly diagnosed glioblastoma. This quarter, ImmunoCellular plans to begin the internation...